Grand MMTI

Grand MMTI - Speeding Development of Improved Multiple Myeloma Therapies

Just two days left to meet our $2.5M fundraising goal

January 02, 2019

Dear Friend,  

 

Please end this year with a special gift to the UCSF Stephen & Nancy Grand Multiple Myeloma Translational Initiative.

 

Donations received by midnight on December 31 count as charitable contributions for 2018, and will usher in the new year of funding for our scientists and clinicians who are passionately committed to improving care for patients with multiple myeloma, and realizing our vision for bringing CAR T-cell therapy to our patients.  

 

Every day, our work has immediacy and importance because of our patients, their loved ones and friends. When visionary partners like you invest in the latest research and the most innovative discovery and care, we transform lives.  

 

Join us in supporting the scientists and clinicians who are at the forefront of patient care – please give now. Thank you for your generosity.

 

Sincerely,

 

Jeff Wolf, MD, Professor of Clinical Medicine, Director, Grand MMTI

Tom Martin, MD, Professor of Medicine, Director, Grand MMTI

 

P.S. Please click on the links below to see videos and learn more from our esteemed Grand MMTI clinical and scientific leaders, explaining our vision to lead trailblazing medical research in the areas of cellular therapies and novel treatment paradigms:

 

Jeff Wolf, MD

UCSF Stephen and Nancy Grand Multiple Myeloma Translational Initiative Program Overview: Our Path to the Present  

 

Sandy Wong, MD

UCSF Stephen and Nancy Grand Multiple Myeloma Translational Initiative: Our Growing Amyloidosis Program  

 

Arun Wiita, MD, PhD

UCSF Stephen and Nancy Grand Multiple Myeloma Translational Initiative: Myeloma Translational Program

 

Matt Spitzer, PhD

UCSF Stephen and Nancy Grand Multiple Myeloma Translational Initiative: Understanding the Immune Microenvironment with Immunotherapies  

 

Nina Shah, MD

UCSF Stephen and Nancy Grand Multiple Myeloma Translational Initiative: A Patient Experience with Cellular Therapies for Multiple Myeloma  

 

Tom Martin, MD

UCSF Stephen and Nancy Grand Multiple Myeloma Translational Initiative Fundraising Vision    

Help us care for patients with multiple myeloma

November 20, 2018

Dear Friend,  

 

Because of generous donors like you, the UCSF Stephen & Nancy Grand Multiple Myeloma Translational Initiative is one of the nation’s premier programs for research and clinical care. 

 

We are the largest multiple myeloma clinical practice and research program on the West Coast, working to improve care for myeloma patients and speed development of improved myeloma therapies. Our program, with its internationally recognized cancer researchers and world-class myeloma clinicians, has the resources and expertise to tackle the complex issues associated with myeloma disease biology and use that knowledge to develop novel treatment approaches.  

 

Grand MMTI physician-scientists are learning how to manipulate and harness a patient’s immune system to seek out and destroy cancer cells. The Grand MMTI is one of the few programs nationwide with the clinical trials expertise and capabilities to administer novel and promising multiple myeloma cellular immunotherapies to our patients.   

 

In this season of giving, we ask you to make an investment in the understanding, treatment, and prevention of multiple myeloma. Your gift will be put to immediate use, helping our scientists discover life-saving treatments and our clinicians deliver them with expertise and compassion.  

 

Help us reach our $2,500,000 year-end fundraising goal by making your year-end gift today. Give patients suffering from multiple myeloma new hope for a cancer-free future. Thank you for your support. In gratitude,

 

Jeff Wolf, MD

Professor of Clinical Medicine

Director, Grand MMTI

 

Tom Martin, MD

Professor of Medicine

Director, Grand MMTI

 

P.S. Your gift will fuel innovative, impactful research leading to improved care for multiple myeloma patients!  Please help us reach our $2,500,000 year-end fundraising goal and give today.  

 

P.P.S. If you would like more information about supporting the UCSF Grand MMTI, please contact Sydney Pietrzak, at 415-502-1197 or Sydney.Pietrzak@ucsf.edu.  

Please support Cellular Immunotherapies for Multiple Myeloma

October 26, 2018

Dear Friend,

 

Through the compassionate support of our donors, the UCSF Stephen & Nancy Grand Multiple Myeloma Translational Initiative is the premier myeloma translational program on the West Coast.  Our team of leading basic scientists in oncology and world-class clinical faculty work side-by-side to pioneer groundbreaking treatments and are leading world-changing medical research in the areas of cellular therapy and novel treatment paradigms.

 

Help us translate that research into lifesaving care for our patients.

 

Join us and donate today to help us reach our goal of raising $2,500,000 by December 31 to fund the clinical development of cancer immunotherapies, known as CAR T-cell therapies, for patients with multiple myeloma.  Early clinical studies with these therapies have demonstrated exciting and very promising results for myeloma patients across the range of disease stages.  While these therapies have the potential to cure disease, we are not there yet.  Work still needs to be done to improve efficacy, increase durability of response and make these therapies available to as many patients as possible.  Your support will help us achieve all these goals for UCSF patients and beyond. 

 

Your gift – and every gift to the Grand MMTI – makes a difference.   It has the power to become the tipping point, when research discoveries are transformed into lifesaving care. On behalf of every patient and family member who battles this disease, thank you.

 

Together, we are bringing new hope to cancer patients. Please give now.

 

With best wishes,

                                                                                               

Jeff Wolf, MD

Professor of Clinical Medicine

Director, Grand MMTI

 

Tom Martin, MD

Professor of Medicine

Director, Grand MMTI

 

 

P.S. Your gifts make cancer immunotherapy innovation and research possible. You are providing seed funding for us to test our most creative new ideas, which in turn lead to even greater funding from industry partners and public grants.  Make your gift today!

 

P.P.S. If you would like more information about supporting the UCSF Grand MMTI, please contact Sydney Pietrzak at 415-502-1197 or Sydney.Pietrzak@ucsf.edu.